Image provided by Erik Orava and Dr. Jean Gariépy Image provided by Erik Orava and Dr. Jean Gariépy Image provided by Suji Thmmalingam Dr. David Hampson Image provided by Suji Thmmalingam Dr. David Hampson

Biotherapeutics Home

Key Dates:

One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
and
Multiplex genome engineering using CRISPR/Cas systems
Dr. Feng Zhang
Department of Brain and Cognitive Sciences
Department of Biological Engineering
Massachusetts Institute of Technology
October 16, 2013 - 12:00pm
Host: Dr. Stephane Angers and Dr. David R. Hampson
Location TBA
CIHR Biological Therapeutics Training Program Seminar

The Biological Therapeutics Training Program is proud to announce its sponsorship and participation in the 2013 Neurobiology Meeting, taking place at the University of Toronto in June, hosted by Dr. Oliver Ernst (Biochemistyr Department) and featuring a keynote address by Brian Kobilka, 2012 Nobel Laureate.

Molecular Modeling in Drug Discovery
Minghua Wang
Scientist, Forma Therapeutics Inc. , Boston
Monday, May 27, 2013 - 11:00am
Host: Dr. David Hampson
Pharmacy Building Room 850
CIHR Biological Therapeutics Training Program Seminar
Co-sponsor: Faculty of Pharmacy


Biological Therapeutic Meetings, University of Toronto, May 2-3, 2013
In Spring 2013, the Biotherapeutics Program will hold two symposia on consecutive days on
1) The Blood Brain Barrier, and
2) Mechanisms of distribution of macromolecules and nanoparticle in tissues
Click here to view full program

Click here to register

 

Congratulations!

Mary Lee (Supervisor: R. Bremner) and
Rachel Mattson (Supervisor: A. Schimmer) winners of the 2012 Biotherapeutics Annual Summer Student Poster Day, August 13.

Dr. Irina Brokhman awarded Hugh Sellers Postdoctoral Fellowship one year award from The Banting & Best Diabetes Centre(BBDC)
(Primary Supervisor: Dr. Derek van der Kooy , Secondary Supervisor: Dr. Shelley Boyd)

Lillian Doss, a Trainee in he program has started an internship at the Millenium Research Group.

Ingrid Xuan, an M.Sc. student in the program is engaged in a 2011 summer internship at Patheon Inc. in Toronto. The position is "Technologist I" in the pharmaceutics and process technology department. She will be responsible for performing formulation, scale up and other manufacturing related assignments in a high potency drug development project.

Dr. Shervin Gholizadeh, Trainee, for being awarded a prestigious Vanier Graduate Scholarship.

 

 

Tumor-penetrating transport of cancer drugs is activated by the peptide iRGD (multicolored ring), which binds to integrin receptors (blue and yellow) in tumor blood vessels, and is subsequently cleaved. The cleaved peptide then binds to neuropilin-1 receptors (purple), activating a transport system that carries coadministered drugs, such as antibodies (green), deeper into tumor tissue.
Image: Peter Allen/University of California, Santa Barbara

Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs, Kazuki N. Sugahara, et al.
Science 328, 1031 (2010);
 

 

 

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer